Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
Konstantin Mehl
|
| gptkbp:focusArea |
chronic disease management
musculoskeletal health digital physical therapy |
| gptkbp:foundedYear |
2016
|
| gptkbp:founder |
Konstantin Mehl
Manuel Thurner |
| gptkbp:headquartersLocation |
gptkb:Germany
gptkb:Munich |
| https://www.w3.org/2000/01/rdf-schema#label |
Kaia Health
|
| gptkbp:industry |
gptkb:insurance
health technology |
| gptkbp:mobileAppAvailable |
yes
|
| gptkbp:notableEvent |
raised $75 million in Series C funding in 2021
|
| gptkbp:notableInvestment |
gptkb:Balderton_Capital
gptkb:Silicon_Valley_Bank gptkb:Heartcore_Capital gptkb:Optum_Ventures 3VC |
| gptkbp:operatesIn |
gptkb:Europe
gptkb:United_States |
| gptkbp:product |
digital therapeutics for COPD
digital therapeutics for chronic pain digital therapeutics for musculoskeletal conditions |
| gptkbp:regulatoryClearance |
FDA Class II medical device (for some products)
|
| gptkbp:website |
https://www.kaiahealth.com/
|
| gptkbp:bfsParent |
gptkb:Mark_Gainey
gptkb:Optum_Ventures |
| gptkbp:bfsLayer |
8
|